Maintenance immunotherapy in advanced urothelial cancer
Advanced urothelial carcinoma usually responds to platinum-based chemotherapy (CT), although overall survival (OS) and progression-free survival are typically short. Immunotherapy is a promising treatment strategy, but the first-line benefits in platinum-eligible patients are limited, and its combin...
Zapisane w:
| Główni autorzy: | , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Permanyer
2022-07-01
|
| Seria: | Gaceta Mexicana de Oncología |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.gamo-smeo.com/frame_esp.php?id=323 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|